TITLE

Clostridium difficile, Aging, and the Gut: Can Microbiome Rejuvenation Keep Us Young and Healthy?

AUTHOR(S)
Fischer, Natalie; Relman, David A.
PUB. DATE
January 2018
SOURCE
Journal of Infectious Diseases;1/15/2018, Vol. 217 Issue 2, p174
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
A review of the article "Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host" by Shin et al., which appeared in the periodical "The Journal of Infectious Diseases" in 2017, is presented.
ACCESSION #
127133613

 

Related Articles

  • Community-Acquired Clostridium difficile Infection, Queensland, Australia. Furuya-Kanamori, Luis; Yakob, Laith; Riley, Thomas V.; Paterson, David L.; Baker, Peter; McKenzie, Samantha J.; Robson, Jenny; Clements, Archie C. A. // Emerging Infectious Diseases;Sep2016, Vol. 22 Issue 9, p1659 

    The article hypothesizes that the observed increase in community-acquired Clostridium difficile infection (CA-CDI) in Queensland from 2003-2012 was associated with increased drug prescriptions. It says that the CDI could not be explained by patients' demographic characteristics or environmental...

  • Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Kelly, Colleen R.; Khoruts, Alexander; Staley, Christopher; Sadowsky, Michael J.; Abd, Mortadha; Alani, Mustafa; Bakow, Brianna; Curran, Patrizia; McKenney, Joyce; Tisch, Allison; Reinert, Steven E.; Machan, Jason T.; Brandt, Lawrence J. // Annals of Internal Medicine;11/1/2016, Vol. 165 Issue 9, p609 

    Background: To date, evidence for the efficacy of fecal microbiota transplantation (FMT) in recurrent Clostridium difficile infection (CDI) has been limited to case series and open-label clinical trials.Objective: To determine the efficacy and safety of FMT for...

  • Clostridium difficile and the microbiota. Seekatz, Anna M.; Young, Vincent B. // Journal of Clinical Investigation;Oct2014, Vol. 124 Issue 10, p4182 

    Clostridium difficile infection (CDI) is the leading health care-associated illness. Both human and animal models have demonstrated the importance of the gut microbiota's capability of providing colonization resistance against C. difficile. Risk factors for disease development include antibiotic...

  • What Factors Lead to Acquisition of Clostridium difficile?  // Hospital Medicine Alert;Jan2012 Clinical Briefs Supplement, p2 

    The article focuses on the study by V. G. Loo and colleagues which examined the host and pathogen factors associated to Clostridium difficile colonization and infection.

  • ICD-9 codes and surveillance for Clostridium difficile-associated disease. Dubberke, Erik R.; Reske, Kimberly A.; McDonald, L. Clifford; Fraser, Victoria J. // Emerging Infectious Diseases;Oct2006, Vol. 12 Issue 10, p1576 

    We conducted a retrospective cohort study to compare Clostridium difficile-associated disease rates determined by C. difficile-toxin assays and International Classification of Diseases, 9th Revision (ICD-9) codes. The correlation between toxin assay results and ICD-9 codes was good (K = 0.72,...

  • Use of postmenopausal estrogen replacement therapy from 1981 to 1997. Csizmadi, Ilona; Benedetti, Andrea; Boivin, Jean-François; Hanley, James A.; Collet, Jean-Paul; Boivin, Jean-François // CMAJ: Canadian Medical Association Journal;1/22/2002, Vol. 166 Issue 2, p187 

    Examines the trends in the prevalence of estrogen use by peri- and post-menopausal women in Saskatchewan from 1981 to 1997. Focus on research on the health benefits and risks of estrogen replacement therapy (ERT); Data which indicate that the prevalence of hormone use has been increasing since...

  • Antibiotic use, comorbid conditions, extended hospital stay linked to increased risk for C. difficile.  // Infectious Disease News;Jul2009, Vol. 22 Issue 7, p19 

    The article discusses a study of the factors associated with the increased risk for Clostridium difficile infection, presented at the 36th International Meeting of the Association for Professionals in Infection Control and Epidemiology in Fort Lauderdale, Florida.

  • Lack of Correlation between Bristol Stool Scale and Quantitative Bacterial Load in Clostridium difficile Infection. Thabit, Abrar K.; Nicolau, David P. // Infectious Diseases: Research & Treatment;2015, Issue 8, p1 

    No abstract available.

  • Possible Association between Obesity and Clostridium difficile Infection. Leung, Jason; Burke, Bob; Ford, Dale; Garvin, Gail; Korn, Cathy; Sulis, Carol; Bhadelia, Nahid // Emerging Infectious Diseases;Nov2013, Vol. 19 Issue 11, p1791 

    Inflammatory bowel disease (IBD) is a risk factor for Clostridium difficile infections (CDIs). Because of similar disruptions to the intestinal microbiome found in IBD and in obesity, we conducted a retrospective study to clarify the role of obesity in CDI. We reviewed records of patients with...

  • Risk Factors for Recurrent Clostridium difficile Infection. Han Seung Ryu; Yong Sung Kim; Geom Seog Seo; Yu Min Lee; Suck Chei Choi // Intestinal Research;2012, Vol. 10 Issue 2, p176 

    substantial morbidity, mortality and increased medical care costs. Although most patients initially respond to therapy, with either metronidazole or vancomycin, about 15-20% of patients experience recurrence. The aim of this study was to analyze the risk factors related to recurrent CDI (RCDI)....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics